Featured Resource
European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second Revision
12:15 MIN
- CIDP
Watch Dr. Peter Van den Bergh, lead author, take you through the highlights of the guideline.
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
14:01 MIN
- CIDP
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Fatigue in CIDP
09:29 MIN
- CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Therapy
8:25 MIN
- CIDP
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
GBS and Zika Virus
19:15 MIN
- GBS
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre┬┤ syndrome
Wear-Off in IVIG and What it Means in Clinical Practice
16:21 MIN
- CIDP
Learn about wear-off effects in patients with CIDP, the tools available to monitor them, and the methods to combat them and tailor treatment to the patient.
SELECT A CHAPTER TO VIEW
Introduction
Introduction to wear-off effects
Monitoring wear-off effects
Combating wear-off effects
Conclusion
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
7:23 MIN
- GBS
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Electrophysiologic Findings In Multifocal Motor Neuropathy
09:15 MIN
- MMN
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
09:51 MIN
- MMN
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
15:18 MIN
- CIDP
- GBS
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
SCIg in Multifocal Motor Neuropathy
10:32 MIN
- MMN
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
13:53 MIN
- CIDP
- GBS
- MMN
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Clinical Studies for the Treatment of CIDP with Immunoglobulin
9:35 MIN
- CIDP
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength Measurements
12:15 MIN
- CIDP
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
Restabilization of chronic inflammatory demyelinating polyneuropathy patients with IVIG: restabilization phase of the PATH study
12:13 MIN
- CIDP
Learn about the Restabilization Phase of the PATH Trial with IVIG in CIDP patients
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5:24 MIN
- CIDP
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Clinical Studies for the Treatment of CIDP with Immunoglobulin
9:35 MIN
- CIDP
- MMN
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
12:30 MIN
- CIDP
Understand the challenges associated with accurately diagnosing CIDP
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
15:31 MIN
- CIDP
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
CIDP Assessment Tools: Grip Strength
01:52 MIN
- CIDP
Listen to a discussion about Discussing tools that are commonly used to measure grip strength in CIDP
IgG Levels and Wear Off Reflect Administration and Outcome
5:51 MIN
- CIDP
- GBS
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
12:50 MIN
- CIDP
- MMN
Review options for individualizing treatment and tools used to assess IgG performance
Incidence of GBS and CIDP Following Influenza Vaccination
25:18 MIN
- CIDP
- GBS
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
3:00 MIN
- CIDP
- MMN
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second Revision
- CIDP
Watch Dr. Peter Van den Bergh, lead author, take you through the highlights of the guideline.
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
- CIDP
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Fatigue in CIDP
- CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Therapy
- CIDP
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
GBS and Zika Virus
- GBS
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre┬┤ syndrome
Wear-Off in IVIG and What it Means in Clinical Practice
- CIDP
Learn about wear-off effects in patients with CIDP, the tools available to monitor them, and the methods to combat them and tailor treatment to the patient.
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
- GBS
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Electrophysiologic Findings In Multifocal Motor Neuropathy
- MMN
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
- MMN
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
- CIDP
- GBS
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
SCIg in Multifocal Motor Neuropathy
- MMN
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
- CIDP
- GBS
- MMN
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
Clinical Studies for the Treatment of CIDP with Immunoglobulin
- CIDP
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength Measurements
- CIDP
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
Restabilization of chronic inflammatory demyelinating polyneuropathy patients with IVIG: restabilization phase of the PATH study
- CIDP
Learn about the Restabilization Phase of the PATH Trial with IVIG in CIDP patients
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- CIDP
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
Clinical Studies for the Treatment of CIDP with Immunoglobulin
- CIDP
- MMN
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
- CIDP
Understand the challenges associated with accurately diagnosing CIDP
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy (PATH): a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial
- CIDP
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
CIDP Assessment Tools: Grip Strength
- CIDP
Listen to a discussion about Discussing tools that are commonly used to measure grip strength in CIDP
IgG Levels and Wear Off Reflect Administration and Outcome
- CIDP
- GBS
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
- CIDP
- MMN
Review options for individualizing treatment and tools used to assess IgG performance
Incidence of GBS and CIDP Following Influenza Vaccination
- CIDP
- GBS
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
- CIDP
- MMN
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Video Library
NOW PLAYING
12:15
European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Guideline on diagnosis and tr...
Watch Dr. Peter Van den Bergh, lead author, take you through the highlights of the guideline.
NOW PLAYING
14:01
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
NOW PLAYING
09:29
Fatigue in CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
NOW PLAYING
8:25
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Th...
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
NOW PLAYING
19:15
GBS and Zika Virus
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre┬┤ syndrome
NOW PLAYING
16:21
Wear-Off in IVIG and What it Means in Clinical Practice
Learn about wear-off effects in patients with CIDP, the tools available to monitor them, and the methods to combat them and tailor treatment to the patient.
NOW PLAYING
7:23
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
NOW PLAYING
09:15
Electrophysiologic Findings In Multifocal Motor Neuropathy
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
NOW PLAYING
09:51
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
NOW PLAYING
15:18
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
NOW PLAYING
10:32
SCIg in Multifocal Motor Neuropathy
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
NOW PLAYING
13:53
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
NOW PLAYING
9:35
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
NOW PLAYING
12:15
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength...
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
NOW PLAYING
12:13
Restabilization of chronic inflammatory demyelinating polyneuropathy patients with IVIG: restabiliza...
Learn about the Restabilization Phase of the PATH Trial with IVIG in CIDP patients
NOW PLAYING
5:24
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
NOW PLAYING
9:35
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
NOW PLAYING
12:30
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Understand the challenges associated with accurately diagnosing CIDP
NOW PLAYING
15:31
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Poly...
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
NOW PLAYING
01:52
CIDP Assessment Tools: Grip Strength
Listen to a discussion about Discussing tools that are commonly used to measure grip strength in CIDP
NOW PLAYING
5:51
IgG Levels and Wear Off Reflect Administration and Outcome
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
NOW PLAYING
12:50
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Review options for individualizing treatment and tools used to assess IgG performance
NOW PLAYING
25:18
Incidence of GBS and CIDP Following Influenza Vaccination
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
NOW PLAYING
3:00
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic...
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Slides & Posters Library
PDF
Dosing Schedules for IVIg: The Use of an Algorithm as a Suggestion for Personalized Dosing
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
PDF
Fatigue in CIDP
Engage in a presentation on the comparison between active and remission disease states in CIDP.
PDF
Consistency Over Time of Strength and Disability Measurements in Patients with CIDP on Stable IgG Th...
Hear the results of a study to understand wear-off effects in CIDP patients during IVIg therapy.
PDF
GBS and Zika Virus
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre┬┤ syndrome
PDF
Overview and Treatment of Guillain-Barr├® Syndrome (GBS)
Learn more about the features, symptoms, diagnosis, and treatment of GBS.
PDF
Electrophysiologic Findings In Multifocal Motor Neuropathy
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
PDF
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
PDF
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
PDF
SCIg in Multifocal Motor Neuropathy
Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.
PDF
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.
PDF
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Learn about clinical studies for the treatment of CIDP with immunoglobulin.
PDF
The GRIPPER study: Quantifying IVIG Treatment-Related Fluctuations in CIDP Using Daily Grip Strength...
Learn more about grip strength as an outcome measure in CIDP and how it is utilized in the Gripper Study as a daily measure of treatment-related fluctuations in IVIg-treated patients.
PDF
Restabilization of chronic inflammatory demyelinating polyneuropathy patients with IVIG: restabiliza...
Learn about the Restabilization Phase of the PATH Trial with IVIG in CIDP patients
PDF
Overview and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Learn more about the mechanism of action, symptoms, diagnosis, and treatment of CIDP.
PDF
Clinical Studies for the Treatment of CIDP with Immunoglobulin
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
PDF
Improving CIDP Diagnosis: The Challenges of Under and Over Diagnosis
Understand the challenges associated with accurately diagnosing CIDP
PDF
20% Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Poly...
Learn about the PATH study results and SCIG (subcutaneous immunoglobulin) treatment in CIDP
PDF
IgG Levels and Wear Off Reflect Administration and Outcome
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
PDF
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
Review options for individualizing treatment and tools used to assess IgG performance
PDF
Incidence of GBS and CIDP Following Influenza Vaccination
Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
PDF
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic...
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Back to Top